- Company Overview for SPERO CANTAB UK LIMITED (10175336)
- Filing history for SPERO CANTAB UK LIMITED (10175336)
- People for SPERO CANTAB UK LIMITED (10175336)
- Registers for SPERO CANTAB UK LIMITED (10175336)
- More for SPERO CANTAB UK LIMITED (10175336)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
30 Sep 2024 | AA | Total exemption full accounts made up to 31 December 2023 | |
22 May 2024 | CS01 | Confirmation statement made on 10 May 2024 with no updates | |
30 Aug 2023 | AA | Total exemption full accounts made up to 31 December 2022 | |
22 May 2023 | CS01 | Confirmation statement made on 10 May 2023 with no updates | |
03 May 2023 | AD03 | Register(s) moved to registered inspection location 5th Floor Halo Counterslip Bristol BS1 6AJ | |
03 May 2023 | AD02 | Register inspection address has been changed to 5th Floor Halo Counterslip Bristol BS1 6AJ | |
29 Sep 2022 | AA | Total exemption full accounts made up to 31 December 2021 | |
06 Jun 2022 | CS01 | Confirmation statement made on 10 May 2022 with no updates | |
07 Oct 2021 | AA | Total exemption full accounts made up to 31 December 2020 | |
10 May 2021 | CS01 | Confirmation statement made on 10 May 2021 with no updates | |
20 Nov 2020 | AA | Total exemption full accounts made up to 31 December 2019 | |
21 May 2020 | CS01 | Confirmation statement made on 10 May 2020 with updates | |
11 Nov 2019 | TM01 | Termination of appointment of Joel Sendek as a director on 8 November 2019 | |
07 Oct 2019 | AA | Group of companies' accounts made up to 31 December 2018 | |
13 May 2019 | CS01 | Confirmation statement made on 10 May 2019 with updates | |
15 Apr 2019 | TM01 | Termination of appointment of Stephen Garbacz as a director on 15 April 2019 | |
15 Apr 2019 | AP01 | Appointment of Mr Joel Sendek as a director on 15 April 2019 | |
08 Nov 2018 | AA | Total exemption full accounts made up to 31 December 2017 | |
03 Aug 2018 | CH01 | Director's details changed for Stephen Garbacz on 3 August 2018 | |
03 Aug 2018 | CH01 | Director's details changed for Ankit Atul Mahadevia on 3 August 2018 | |
03 Aug 2018 | CH01 | Director's details changed for Stephen Garbacz on 3 August 2018 | |
14 May 2018 | PSC02 | Notification of Spero Therapeutics, Inc. as a person with significant control on 13 June 2017 | |
14 May 2018 | PSC09 | Withdrawal of a person with significant control statement on 14 May 2018 | |
14 May 2018 | CS01 | Confirmation statement made on 10 May 2018 with updates | |
04 Oct 2017 | AA | Total exemption full accounts made up to 31 December 2016 |